{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,12]],"date-time":"2025-10-12T10:59:20Z","timestamp":1760266760969},"reference-count":30,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2007,3,1]],"date-time":"2007-03-01T00:00:00Z","timestamp":1172707200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["International Journal of Radiation Oncology*Biology*Physics"],"published-print":{"date-parts":[[2007,3]]},"DOI":"10.1016\/j.ijrobp.2006.10.034","type":"journal-article","created":{"date-parts":[[2007,3,1]],"date-time":"2007-03-01T21:29:54Z","timestamp":1172784594000},"page":"995-1001","source":"Crossref","is-referenced-by-count":9,"title":["Phase I North Central Cancer Treatment Group Trial-N9923 of escalating doses of twice-daily thoracic radiation therapy with amifostine and with alternating chemotherapy in limited stage small-cell lung cancer"],"prefix":"10.1016","volume":"67","author":[{"given":"Yolanda I.","family":"Garces","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Scott H.","family":"Okuno","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Steven E.","family":"Schild","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sumithra J.","family":"Mandrekar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Brian M.","family":"Bot","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"John M.","family":"Martens","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Donald B.","family":"Wender","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gamini S.","family":"Soori","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"suffix":"Jr.","given":"Dennis F.","family":"Moore","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Timothy F.","family":"Kozelsky","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"James R.","family":"Jett","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.ijrobp.2006.10.034_bib1","doi-asserted-by":"crossref","first-page":"8","DOI":"10.3322\/canjclin.54.1.8","article-title":"Cancer statistics, 2004","volume":"54","author":"Jemal","year":"2004","journal-title":"CA Cancer J Clin"},{"key":"10.1016\/j.ijrobp.2006.10.034_bib2","doi-asserted-by":"crossref","first-page":"4553","DOI":"10.1200\/JCO.2003.04.018","article-title":"Radiotherapy patterns of care study in lung carcinoma","volume":"21","author":"Movsas","year":"2003","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.ijrobp.2006.10.034_bib3","doi-asserted-by":"crossref","first-page":"1618","DOI":"10.1056\/NEJM199212033272302","article-title":"A meta-analysis of thoracic radiotherapy for small cell lung cancer","volume":"327","author":"Pignon","year":"1992","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ijrobp.2006.10.034_bib4","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1056\/NEJM199901283400403","article-title":"Twice-daily compared with once-daily thoracic radiotherapy in limited small cell lung cancer treated concurrently with cisplatin and etoposide","volume":"340","author":"Turrisi","year":"1999","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ijrobp.2006.10.034_bib5","doi-asserted-by":"crossref","first-page":"943","DOI":"10.1016\/j.ijrobp.2004.01.055","article-title":"Long-term results of a phase III trial comparing once-daily radiotherapy with twice-daily radiotherapy in limited stage small cell lung cancer","volume":"59","author":"Schild","year":"2004","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.ijrobp.2006.10.034_bib6","doi-asserted-by":"crossref","first-page":"912","DOI":"10.1056\/NEJM198704093161504","article-title":"Chemotherapy with or without radiation therapy in limited small-cell carcinoma of the lung","volume":"316","author":"Perry","year":"1987","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ijrobp.2006.10.034_bib7","doi-asserted-by":"crossref","first-page":"4837","DOI":"10.1200\/JCO.2004.01.178","article-title":"Systematic review evaluating the timing of thoracic radiation therapy in combined modality therapy for limited stage small cell lung cancer","volume":"22","author":"Fried","year":"2004","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.ijrobp.2006.10.034_bib8","series-title":"Advances in radiation oncology in lung cancer","first-page":"111","article-title":"Target volumes in small cell lung cancer","author":"Garces","year":"2005"},{"key":"10.1016\/j.ijrobp.2006.10.034_bib9","doi-asserted-by":"crossref","first-page":"2681","DOI":"10.1200\/JCO.1999.17.9.2681","article-title":"Phase III comparison of twice-daily split-course irradiation versus once-daily irradiation for patients with limited stage small cell lung carcinoma","volume":"17","author":"Bonner","year":"1999","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.ijrobp.2006.10.034_bib10","first-page":"2","article-title":"Cisplatin plus etoposide in small cell lung cancer","volume":"15","author":"Loehrer","year":"1988","journal-title":"Semin Oncol"},{"key":"10.1016\/j.ijrobp.2006.10.034_bib11","doi-asserted-by":"crossref","first-page":"2498","DOI":"10.1002\/cncr.11377","article-title":"Alternating chemotherapy with etoposide plus cisplatin and topotecan plus paclitaxel in patients with untreated, extensive-stage small cell lung carcinoma: A phase II trial of the North Central Cancer Treatment Group","volume":"97","author":"Jett","year":"2003","journal-title":"Cancer"},{"key":"10.1016\/j.ijrobp.2006.10.034_bib12","doi-asserted-by":"crossref","first-page":"2230","DOI":"10.1200\/JCO.1995.13.9.2230","article-title":"Phase I study of paclitaxel and topotecan in patients with advanced tumors: A cancer and leukemia group B study","volume":"13","author":"Lilenbaum","year":"1995","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.ijrobp.2006.10.034_bib13","doi-asserted-by":"crossref","first-page":"2743","DOI":"10.1200\/JCO.1994.12.12.2743","article-title":"Phase I study of topotecan and cisplatin in patients with advanced solid tumors: A cancer and leukemia group B study","volume":"12","author":"Miller","year":"1994","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.ijrobp.2006.10.034_bib14","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1016\/S0169-5002(02)00149-6","article-title":"Cisplatin-etoposide alternating with topotecan in patients with extensive stage small cell lung cancer (SCLC)","volume":"38","author":"Mavroudis","year":"2002","journal-title":"Lung Cancer"},{"key":"10.1016\/j.ijrobp.2006.10.034_bib15","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1081\/CNV-100102549","article-title":"A phase II study of weekly alternating chemotherapy in extensive-stage small cell lung cancer","volume":"19","author":"Kalemkerian","year":"2001","journal-title":"Cancer Invest"},{"key":"10.1016\/j.ijrobp.2006.10.034_bib16","doi-asserted-by":"crossref","first-page":"584","DOI":"10.1200\/JCO.1986.4.4.584","article-title":"WR-2721 protects against the hematologic toxicity of cyclophosphamide: A controlled phase II trial","volume":"4","author":"Glover","year":"1986","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.ijrobp.2006.10.034_bib17","doi-asserted-by":"crossref","first-page":"1369","DOI":"10.1016\/j.ijrobp.2003.10.005","article-title":"Effects of amifostine on acute toxicity from concurrent chemotherapy and radiotherapy for inoperable non-small-cell lung cancer: Report of a randomized comparative trial","volume":"58","author":"Komaki","year":"2004","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.ijrobp.2006.10.034_bib18","doi-asserted-by":"crossref","first-page":"2145","DOI":"10.1200\/JCO.2005.07.167","article-title":"Randomized trial of amifostine in locally advanced non-small-cell lung cancer patients receiving chemotherapy and hyperfractionated radiation: Radiation Therapy Oncology Group trial 98-01","volume":"23","author":"Movsas","year":"2005","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.ijrobp.2006.10.034_bib19","doi-asserted-by":"crossref","first-page":"784","DOI":"10.1016\/j.ijrobp.2005.06.023","article-title":"Amifostine reduces side effects and improves complete response rate during radiotherapy: Results of a meta-analysis","volume":"64","author":"Sasse","year":"2006","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.ijrobp.2006.10.034_bib20","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1093\/jnci\/92.3.205","article-title":"New guidelines to evaluate the response to treatment in solid tumors","volume":"92","author":"Therasse","year":"2000","journal-title":"J Natl Cancer Inst"},{"key":"10.1016\/j.ijrobp.2006.10.034_bib21","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1016\/0021-9681(81)90058-8","article-title":"Measuring the quality of life of cancer patients: A concise QL-index for use by physicians","volume":"34","author":"Spitzer","year":"1981","journal-title":"J Chronic Dis"},{"key":"10.1016\/j.ijrobp.2006.10.034_bib22","doi-asserted-by":"crossref","first-page":"925","DOI":"10.2307\/2531693","article-title":"Design and analysis of phase I clinical trials","volume":"45","author":"Storer","year":"1989","journal-title":"Biometrics"},{"key":"10.1016\/j.ijrobp.2006.10.034_bib23","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1080\/01621459.1958.10501452","article-title":"Nonparametric estimation from incomplete observations","volume":"53","author":"Kaplan","year":"1958","journal-title":"J Am Stat Assoc"},{"key":"10.1016\/j.ijrobp.2006.10.034_bib24","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1093\/annonc\/mdh061","article-title":"Phase II study of topotecan and paclitaxel for patients with previously untreated extensive stage small-cell lung cancer","volume":"15","author":"Ramalingam","year":"2004","journal-title":"Ann Oncol"},{"key":"10.1016\/j.ijrobp.2006.10.034_bib25","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/S0169-5002(03)00139-9","article-title":"Phase I\/II study of altered schedule of cisplatin and etoposide administration and concurrent accelerated hyperfractionated thoracic radiotherapy for limited stage small cell lung cancer","volume":"41","author":"Segawa","year":"2003","journal-title":"Lung Cancer"},{"key":"10.1016\/j.ijrobp.2006.10.034_bib26","doi-asserted-by":"crossref","first-page":"40","DOI":"10.3816\/CLC.2003.n.020","article-title":"Phase I study of weekly alternating therapy with irinotecan\/cisplatin and etoposide\/cisplatin for patients with small cell lung cancer","volume":"5","author":"Johnson","year":"2003","journal-title":"Clin Lung Cancer"},{"key":"10.1016\/j.ijrobp.2006.10.034_bib27","doi-asserted-by":"crossref","first-page":"4991","DOI":"10.1200\/JCO.2005.00.414","article-title":"Study of paclitaxel, etoposide, and cisplatin chemotherapy combined with twice-daily thoracic radiotherapy for patients with limited stage small cell lung cancer: A Radiation Therapy Oncology Group 9609 phase II study","volume":"23","author":"Ettinger","year":"2005","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.ijrobp.2006.10.034_bib28","doi-asserted-by":"crossref","first-page":"342","DOI":"10.1016\/j.ijrobp.2004.11.030","article-title":"Phase I study of thoracic radiation dose escalation with concurrent chemotherapy for patients with limited small-cell lung cancer: Report of Radiation Therapy Oncology Group (RTOG) protocol 97-12","volume":"62","author":"Komaki","year":"2005","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.ijrobp.2006.10.034_bib29","doi-asserted-by":"crossref","unstructured":"Sunpaweravong P, Magree L, Rabinovitch R, et al. A Phase I\/II study of docetaxel, etoposide, and carboplatin before concurrent chemoradiotherapy with cisplatin and etoposide in limited stage small cell lung cancer. Invest New Drugs 2006.","DOI":"10.1007\/s10637-005-3669-3"},{"key":"10.1016\/j.ijrobp.2006.10.034_bib30","doi-asserted-by":"crossref","first-page":"5418","DOI":"10.1158\/1078-0432.CCR-04-0436","article-title":"Phase I study of tirapazamine plus cisplatin\/etoposide and concurrent thoracic radiotherapy in limited stage small cell lung cancer (S0004): A Southwest Oncology Group study","volume":"10","author":"Le","year":"2004","journal-title":"Clin Cancer Res"}],"container-title":["International Journal of Radiation Oncology*Biology*Physics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0360301606033803?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0360301606033803?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,1,9]],"date-time":"2019-01-09T01:24:09Z","timestamp":1546997049000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0360301606033803"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2007,3]]},"references-count":30,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2007,3]]}},"alternative-id":["S0360301606033803"],"URL":"https:\/\/doi.org\/10.1016\/j.ijrobp.2006.10.034","relation":{},"ISSN":["0360-3016"],"issn-type":[{"value":"0360-3016","type":"print"}],"subject":[],"published":{"date-parts":[[2007,3]]}}}